Researchers are reporting that the risks from monoclonal antibody treatments for Alzheimer's appear to outweigh the benefits, so these therapies probably people shouldn't be used on most people with the disease
UGA study questions benefits of new Alzheimer s drug – WGAU wgauradio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wgauradio.com Daily Mail and Mail on Sunday newspapers.
The effectiveness of a new drug used to treat Alzheimer’s was called into question by a recent University of Georgia study, according to a Jan. 22 press release.